NCT05102396View on ClinicalTrials.gov

Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?

PHASE2RecruitingINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

August 30, 2024

Conditions
HyperhidrosisOxybutyninSweat Gland DiseasesSkin DiseasesAutonomic AgentsCholinergic AntagonistsParasympatholytics
Interventions
DRUG

Topical oxybutynin spray

Participants will receive topical oxybutynin spray (10%).

DRUG

Topical placebo spray

Participants will receive topical placebo spray.

DRUG

Oral oxybutynin

Participants will receive oxybutynin (tablets).

Trial Locations (1)

01.223-001

RECRUITING

Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo

All Listed Sponsors
collaborator

Science Valley Research Institute

OTHER

lead

Samantha Rodrigues Camargo Neves de Moura

OTHER